Skip to main content

Journals in Inflammation and allergy

Comparative Immunology Reports

  • ISSN: 2667-0119
Comparative Immunology Reports is a new, online only, open access journal and a companion title to the highly-regarded journals Fish & Shellfish Immunology and Developmental & Comparative Immunology.Comparative Immunology Reports publishes high-quality, peer-refereed contributions in all areas of immunology, including comparative aspects of immunity and the evolution of the immune system of vertebrates and invertebrates in a rapid open-access format. It accepts studies on the basic mechanisms of both the specific and non-specific defense systems, including cells, tissues, proteins and genes. Reports on the influence of environmental and intrinsic factors, response to pathogens and the mechanistic and functional aspects of immunity are welcomed.
Comparative Immunology Reports

Comparative Immunology Reports

  • ISSN: 2950-3116
Comparative Immunology Reports is a new, online only, open access journal and a companion title to the highly-regarded journals Fish & Shellfish Immunology and Developmental & Comparative Immunology.Comparative Immunology Reports publishes high-quality, peer-refereed contributions in all areas of immunology, including comparative aspects of immunity and the evolution of the immune system of vertebrates and invertebrates in a rapid open-access format. It accepts studies on the basic mechanisms of both the specific and non-specific defense systems, including cells, tissues, proteins and genes. Reports on the influence of environmental and intrinsic factors, response to pathogens and the mechanistic and functional aspects of immunity are welcomed.
Comparative Immunology Reports

Immunobiology

  • ISSN: 0171-2985
  • 5 Year impact factor: 2.7
  • Impact factor: 2.5
Immunobiology is a broad-scope and inclusive Gold Open Access journal dedicated to publishing innovative research across a wide range of immunological subjects. Immunobiology aims to foster a comprehensive understanding of immunology by bridging the gap between scientists and clinicians.The journal publishes topics including:Innate and Adaptive Immunity Molecular Mechanisms, Including Normal and Pathological Functions of the Immune Response, Immune Cell Biology, Cytokines, and Soluble Mediators. Complement Biology, Pathology, and Therapeutics. Microbial Immunology and Immunopathology of Infectious Diseases (Bacterial, Viral and Parasitic) Cancer Immunology Neuroimmunology Immunogenetics Immunopathology of allergic and autoimmune diseases Vaccines and Immunotherapeutics Clinical Immunology Immunobiology does not accept submissions consisting mainly of (a) bioinformatics or computational analysis of public genomic or transcriptomic databases and (b) testing and evaluation of previously uncharacterized natural product-based drug candidates. Immunobiology does not accept reviews that are not by invitation.Founded in 1909 as the first-ever specialist immunology journal, Immunobiology has a rich history of contributing to the field. It aims to become the most inclusive journal for the dissemination of rigorous immunological research, supporting the global scientific community in advancing the field.
Immunobiology

International Immunopharmacology

  • ISSN: 1567-5769
  • 5 Year impact factor: 5
  • Impact factor: 4.8
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions. • Studies on the nature and function of drug and hormone receptors on lymphocytes and other cells in the immune system.• Studies of cell-derived or humoral factors that modify the immune system causing cytotoxicity, inducing antibody production and mediating inflammatory responses. • The development of immunologically based assays and their application to disease, including assays for drugs, hormones, cyclic nucleotides, tumor antigens, etc. • The Editors will be pleased to receive published books for possible independent review.Please Bookmark this URL: https://www.elsevier.com/locate/intimp These Backfiles include Immunopharmacology and the International Journal of Immunopharmacology .
International Immunopharmacology

Journal of Allergy and Hypersensitivity Diseases

  • ISSN: 2950-3124
Official publication of the Societe francaise d'allergologie (French society of allergy).ScopeThe Journal of Allergy and Hypersensitivity Diseases (JAHD) is a peer-reviewed, open-access journal in the fields of allergy and immunology. It covers all aspects of the fields, including clinical, educational, and translational research, associated with new technologies, epidemiology, public health and environmental aspects. JAHD is an international platform for promoting and disseminating findings in quality original articles, guidelines, reviews, and short communications to a wide audience.AimsThe JAHD supports modern and traditional approaches and public health strategies to improve the quality care of patients with allergy, asthma and hypersensitivity. An international team of experts counts as part of the editorial board and reviewers, who ensure dynamic peer-review and timely high impact scientific publications.ContentAll JAHD content will be peer-reviewed. The journal welcomes original articles covering the spectrum of conditions managed by allergists in clinical practice, such as:anaphylaxisdrug-related allergyfood and insect sting allergic and hypersensitivity conditionsallergic and hypersensitivity conditions affecting the eyesskin and respiratory tract conditionseosinophilic and mast cell disordersepidemiological, environmental, mechanistic, and diagnostic researchThe JAHD will present results from these areas in original papers, review articles and short communications. This research must advance the understanding of an allergic condition or medical treatment and contribute to improving the quality of care of patients with allergy, asthma, and hypersensitivity.Article typesThe JAHD will consider articles, reviews, technical notes and letters to the editors for publication, provided that the methodology and the scientific content are of high quality and the results have substantial clinical impact.Publication scheduleThe journal will be published in e-only format and 2 issues in the first year, 4 issues in the second, third and fourth years, and every 2 months in year 5 and after (6 issues per year). The journal will use a fast production workflow, with article-based publishing and article numbering.Editorial board and processesArticle quality will be assured by an international and gender-balanced editorial board nominated by the editor-in-chief.
Journal of Allergy and Hypersensitivity Diseases

Transplant Immunology

  • ISSN: 0966-3274
  • 5 Year impact factor: 1.5
  • Impact factor: 1.6
Transplant Immunology will publish up-to-date information on all aspects of the broad field it encompasses. The journal is directed to general scientific and medical audience but in particular to basic and applied scientists, transplant-related laboratory personnel, transplant physicians and surgeons. The journal will present research reports and clinical data on all immunological aspects of organ-, tissue-, and haematopoietic stem cell transplantation. Furthermore, the journal is interested to publish high quality basic and clinical research in immunology, physiology and pathophysiology related to processes and diseases affecting transplant patients. Original papers, Brief reports, Cases reports and Review articles and Hypotheses will be considered for publication. Submitted manuscripts will be rapidly peer-reviewed and published. They will be judged on the basis of scientific merit, originality, timeliness and quality.
Transplant Immunology